All Stories

  1. Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis

    Article • Expert Opinion on Biological Therapy, September 2019, Taylor & Francis

    Hyoun-ah Kim, Dr Chang-Hee Suh

  2. Biomarkers for adult-onset still’s disease: up-to-date

    Article • Expert Review of Molecular Diagnostics, July 2019, Taylor & Francis

    Hyoun-ah Kim

  3. The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still’s disease

    Article • Expert Review of Molecular Diagnostics, May 2019, Taylor & Francis

    Hyoun-ah Kim, Dr Chang-Hee Suh

  4. Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still’s disease

    Article • International Journal of Immunopathology and Pharmacology, March 2018, SAGE Publications

    Hyoun-ah Kim

  5. An update: current and prospective treatments for adult-onset Still’s disease

    Article • Expert Opinion on Orphan Drugs, April 2017, Taylor & Francis

    Dr Chang-Hee Suh, Hyoun-ah Kim

  6. The Correlation of CD206, CD209, and Disease Severity in Behçet’s Disease with Arthritis

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    Dr Chang-Hee Suh, Hyoun-ah Kim

  7. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA

    Article • Lupus, March 2016, SAGE Publications

    Hyoun-ah Kim

  8. Thrombocytopenia in Systemic Lupus Erythematosus

    Article • Medicine, February 2016, Wolters Kluwer Health

    Hyoun-ah Kim